Shepherd Kaplan Krochuk, LLC Cara Therapeutics, Inc. Transaction History

Shepherd Kaplan Krochuk, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $366,386 - $608,642	-31,585 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$11.77 - $16.08 $60,227 - $82,281	5,117 Added 19.33%	31,585 $391,000
Q4 2017 Feb 13, 2018	SELL	$11.86 - $14.08 $313,922 - $372,683	-26,469 Reduced 50.0%	26,468 $324,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $667,006 - $864,990	52,937	52,937 $725,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.